1. THU0088 Structural damage progression in patients treated with methotrexate, baricitinib monotherapy or baricitinib + methotrexate based on their level of clinical response in the phase 3 ra-begin study. (15th June 2017) Authors: Heijde, D van der; Durez, P; Schett, G; Naredo, E; Østergaard, M; Meszaros, G; Bello, N; Torre, I De la; Lopez-Romero, P; Schlichting, D; Nantz, E; Fleischmann, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗